Compare drug product CDMOs for formulation development, solid oral dosage, sterile injectables, and specialty dosage forms. Filter by dosage type, scale, and certifications.
1365 companies listed
Drug product manufacturing transforms active pharmaceutical ingredients into the finished dosage forms patients use. This includes solid oral dosage (tablets, capsules), sterile injectables (vials, pre-filled syringes), semi-solids (creams, gels), and specialty forms (transdermal patches, inhalers, implants).
Formulation development is where science meets engineering. A CDMO's formulation team determines bioavailability, stability, and manufacturability. For poorly soluble compounds, techniques like spray drying, hot melt extrusion, and nano-milling can be the difference between a viable product and a failed program. Ask for specific experience with your compound class.
What scale do you need? Clinical-phase drug product often runs in batches of 5,000-50,000 units. Commercial scale might mean millions of units per month. Few CDMOs cover the full range efficiently. Match your current and projected volumes to a CDMO with the right equipment and batch size flexibility.
India
Midas Care Pharmaceutical Pvt. Ltd. is an Indian pharmaceutical manufacturer based in Mumbai (Goregaon), producing branded consumer healthcare and OTC products including IPA sprays, powders, creams, and oral sprays. Products include Clean and Dry, Spraymint, Coolex, and Mistdress brands. The company has an FDA-registered facility and has received 3 FDA inspections (all VAI). While it has some contract manufacturing capability, it primarily operates as a branded product manufacturer.
Germany
Midas Pharma GmbH is a German pharmaceutical company headquartered in Ingelheim, providing end-to-end services across the pharmaceutical value chain including contract development, contract manufacturing, supply chain management, regulatory affairs, quality and compliance, IP services, and reference product sourcing. The company has a particular specialization in Hot Melt Extrusion (HME) technology for high potent drugs with over 10 years of hands-on experience. Midas has FDA and EU GMP-certified manufacturing sites and offers contract manufacturing of finished dosage forms, intermediates, and drug substances. They also have a biosimilar pipeline including Ranibizumab.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.